Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chilcott

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Avoiding and Identifying Errors and Other Threats To the Credibility of Health Economic ModelsP Tappenden, J Chilcott
Nursing Times|April 17, 2002
Nurse-friendly integrated care pathwaysJ Chilcott, A Hunt
Cytopathology : Official Journal of the British Society for Clinical Cytology|February 24, 2001
Liquid-based cytology for cervical screeningN Payne, J Chilcott, E McGoogan
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 7, 2012
Reappraisal of the options for colorectal cancer screening in EnglandS Whyte, J Chilcott, S Halloran
Health Technology Assessment (Winchester, England)|August 10, 2000
Liquid-based cytology in cervical screening: a rapid and systematic reviewN Payne, J Chilcott, E McGoogan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials"Jon Karnon, A Brennan, J Chilcott
Health Technology Assessment (Winchester, England)|July 2, 2009
Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisalJ Chilcott, M Lloyd Jones, A Wilkinson
British Journal of Cancer|September 3, 2014
Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening ProgrammeB Kearns, S Whyte, J Chilcott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa Dehydrogenase Deficiency (Lchadd)A Bessey, J Chilcott, A Pandor, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donorsJ Wight, J Chilcott, M Holmes, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Avoiding and Identifying Errors and Other Threats To the Credibility of Health Economic ModelsP Tappenden, J Chilcott
Nursing Times|April 17, 2002
Nurse-friendly integrated care pathwaysJ Chilcott, A Hunt
Cytopathology : Official Journal of the British Society for Clinical Cytology|February 24, 2001
Liquid-based cytology for cervical screeningN Payne, J Chilcott, E McGoogan
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 7, 2012
Reappraisal of the options for colorectal cancer screening in EnglandS Whyte, J Chilcott, S Halloran
Health Technology Assessment (Winchester, England)|August 10, 2000
Liquid-based cytology in cervical screening: a rapid and systematic reviewN Payne, J Chilcott, E McGoogan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 21, 2004
Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials"Jon Karnon, A Brennan, J Chilcott
Health Technology Assessment (Winchester, England)|July 2, 2009
Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisalJ Chilcott, M Lloyd Jones, A Wilkinson
British Journal of Cancer|September 3, 2014
Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening ProgrammeB Kearns, S Whyte, J Chilcott, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa Dehydrogenase Deficiency (Lchadd)A Bessey, J Chilcott, A Pandor, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donorsJ Wight, J Chilcott, M Holmes, et al.
Pageof 5